首页 | 本学科首页   官方微博 | 高级检索  
   检索      


MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity
Institution:1. Departments of Discovery Biology Cardiovascular and Fibrosis, Bristol Myers Squibb, Princeton, NJ 08543, USA;2. Translational Medicine, Bristol Myers Squibb, Lawrenceville, NJ 08543, USA;3. Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Princeton, NJ 08543, USA;4. Global Drug Development, Bristol Myers Squibb, Lawrenceville, NJ 08543, USA;5. ICF Early Clinical Development, Bristol Myers Squibb, Summit, NJ 07901, USA;6. Translational Bioinformatics, Bristol Myers Squibb, Princeton, NJ 08543, USA;7. Clinical Pharmacology, Bristol Myers Squibb, Lawrenceville, NJ 08543, USA;8. Leads Discovery and Optimization, Bristol Myers Squibb, Princeton, NJ 08543, USA;9. Small Molecule Drug Discovery, Bristol Myers Squibb, Princeton, NJ 08543, USA
Abstract:
><ol class=
  • Download : Download high-res image (177KB)
  • Download : Download full-size image
  • Keywords:MGAT2  NASH  NAFLD  liver fibrosis  steatosis  dicarboxylic acid  DCA  weight loss  DGAT  GLP-1  PYY
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号